Cancer cell bioenergetics, maintaining mixed aerobic glycolysis (Warburg phenotype) and oxidative phosphorylation (OXPHOS), is not fully elucidated. Hypoxia-dependent OXPHOS suppression determines aerobic glycolysis. To elucidate further details, we studied hypoxic adaptation (up to 72 h at 5 % oxygen) of hepatocellular carcinoma HepG2 cells. The key regulatory component, hypoxia-inducible factor (HIF)-1α (HIF-1α) was stabilized at 5 h in 5 % oxygen for all three studied regimens, i.e. in glycolytic cells at 5 mM or 25 mM glucose, or in aglycemic (OXPHOS) cells when glucose was replaced by galactose. However, the conventional HIF-mediated suppression of respiration was prevented at aglycemia, which correlated with a high proportion of unphosphorylated pyruvate dehydrogenase (PDH) at 5 % oxygen. Such a modified HIF response in OXPHOS cells, termed as a non-canonical one, contrasted to conventional respiration suppression down to 45 % or 43 %, observed in hypoxia-adapted glycolytic cells at 5 mM or 25 mM glucose, respectively. These hypoxic glycolytic cells had normally highly phosphorylated PDH and most likely utilized pyruvate by aminotransferase reaction of glutaminolysis to feed at least suppressed respiration. Also, glycolytic cells were rather resistant towards the staurosporine-induced apoptosis, whereas aglycemic (OXPHOS) HepG2 cells exhibited much higher susceptibility. We conclude that aglycemia modulates the hypoxic HIF signaling toward a non-canonical response that is unable to carry out complete PDH phosphorylation, allowing a high pyruvate input for OXPHOS from the elevated glycolysis, which together with ongoing glutaminolysis maintain a virtually unchanged respiration. Similar OXPHOS revival may explain distinct tumor sensitivity to chemotherapy and other pharmacological interventions.

Department of Membrane Transport Biophysics No 75 Institute of Physiology Academy of Sciences of the Czech Republic Vídeňská 1083 14220 Prague 4 Czech Republic

Zobrazit více v PubMed

Science. 2010 Sep 17;329(5998):1492-9 PubMed

Mol Cancer Ther. 2015 Aug;14(8):1928-38 PubMed

Biochim Biophys Acta. 2011 Jul;1813(7):1263-8 PubMed

Cell Cycle. 2008 Jul 15;7(14):2083-9 PubMed

Cell Metab. 2005 Jun;1(6):393-9 PubMed

J Biol Chem. 2004 Feb 20;279(8):6753-60 PubMed

Int J Biochem Cell Biol. 2010 May;42(5):604-22 PubMed

Cell Metab. 2014 Feb 4;19(2):285-92 PubMed

J Cell Biol. 2007 Jul 2;178(1):93-105 PubMed

J Biol Chem. 1980 May 10;255(9):3844-8 PubMed

Antioxid Redox Signal. 2007 Aug;9(8):1221-35 PubMed

Cell Metab. 2005 Jun;1(6):401-8 PubMed

Nature. 2013 Apr 4;496(7443):38-40 PubMed

Cell. 2012 Feb 3;148(3):399-408 PubMed

Biochem Biophys Res Commun. 2014 Aug 22;451(2):288-94 PubMed

Cell Metab. 2006 Mar;3(3):177-85 PubMed

Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36 PubMed

Int J Biochem Cell Biol. 2013 Jul;45(7):1356-65 PubMed

World J Gastroenterol. 2012 Aug 7;18(29):3775-81 PubMed

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20 PubMed

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18782-7 PubMed

Int J Biochem Cell Biol. 2015 Aug;65:125-33 PubMed

Trends Pharmacol Sci. 2012 Apr;33(4):207-14 PubMed

Nature. 2008 Mar 13;452(7184):230-3 PubMed

Cell Mol Life Sci. 2013 Jun;70(11):2015-29 PubMed

Cell. 2013 May 9;153(4):840-54 PubMed

Cancer Biol Ther. 2013 Feb;14(2):81-9 PubMed

J Biol Chem. 2013 Jul 19;288(29):20768-75 PubMed

Cell Biochem Funct. 2013 Aug;31(6):451-9 PubMed

Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1553-8 PubMed

Am J Physiol. 1996 Oct;271(4 Pt 1):C1172-80 PubMed

Free Radic Biol Med. 2007 Apr 1;42(7):1062-74 PubMed

Biochem J. 2008 Jan 1;409(1):19-26 PubMed

PLoS One. 2013;8(3):e56628 PubMed

Cell Rep. 2015 Feb 12;:null PubMed

Int J Biochem Cell Biol. 2013 Jan;45(1):123-9 PubMed

EMBO J. 2012 May 30;31(11):2448-60 PubMed

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9116-21 PubMed

Mol Pharmacol. 2014 May;85(5):651-7 PubMed

Int J Biochem Cell Biol. 2011 Jul;43(7):950-68 PubMed

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21660-5 PubMed

J Pathol. 2013 Apr;229(5):755-64 PubMed

Mol Cell. 2011 Dec 23;44(6):864-77 PubMed

Nature. 2008 Mar 13;452(7184):181-6 PubMed

Science. 2009 May 22;324(5930):1076-80 PubMed

PLoS One. 2013 Apr 30;8(4):e62758 PubMed

Nat Rev Cancer. 2008 Sep;8(9):705-13 PubMed

Respir Physiol Neurobiol. 2010 Dec 31;174(3):175-81 PubMed

Science. 2009 Aug 14;325(5942):834-40 PubMed

Fed Proc. 1984 Jan;43(1):121-5 PubMed

J Cell Sci. 2013 Mar 15;126(Pt 6):1454-63 PubMed

Mol Genet Metab. 2014 Aug;112(4):275-9 PubMed

Antioxid Redox Signal. 2012 Feb 1;16(3):203-16 PubMed

Cell. 2007 Apr 6;129(1):111-22 PubMed

Essays Biochem. 2012;52:23-35 PubMed

Oncogene. 2011 Jun 30;30(26):2986-96 PubMed

J Clin Invest. 2013 Sep;123(9):3664-71 PubMed

Sci Signal. 2009 Nov 17;2(97):ra73 PubMed

Nature. 2011 Nov 20;481(7381):380-4 PubMed

J Cell Biol. 2007 Jun 18;177(6):1029-36 PubMed

Br J Cancer. 2008 Jun 17;98 (12 ):1975-84 PubMed

Cancer Res. 2004 Feb 1;64(3):985-93 PubMed

Biochem J. 2007 Jul 1;405(1):1-9 PubMed

Mol Cell Biol. 2001 May;21(10):3436-44 PubMed

Biochim Biophys Acta. 2013 Oct;1830(10):4743-51 PubMed

Mitochondrial Physiology of Cellular Redox Regulations

Mitochondrial Cristae Morphology Reflecting Metabolism, Superoxide Formation, Redox Homeostasis, and Pathology

Pitfalls of Mitochondrial Redox Signaling Research

Mitochondrial Superoxide Production Decreases on Glucose-Stimulated Insulin Secretion in Pancreatic β Cells Due to Decreasing Mitochondrial Matrix NADH/NAD+ Ratio

Redox Signaling from Mitochondria: Signal Propagation and Its Targets

Aglycemic HepG2 Cells Switch From Aminotransferase Glutaminolytic Pathway of Pyruvate Utilization to Complete Krebs Cycle at Hypoxia

Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling